Slide 1: OptimizeRx Corporation
OPTIMIZERx Corporation — OPTIMIZERx Corporation
Slide 2: Safe Harbor
SAFE HARBOR : This presentation contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The word
Slide 3: SampleMD: Our primary product offering
SampleMD: Our primary product offering = SampleMD is a software platform that allows pharmaceutical and other interested companies to present co-pay and voucher offers directly in the doctor’s prescribing workflow. = The SampleMD platform resides within our partners ePrescribe or electronic health r
Slide 4: SampleMD is a highly-leverageable platform
SampleMD is a highly-leverageable platform = SampleMD, by partnering with the rapidly-expanding EHR/EMR market, is able to be within the primary workflow of hundreds of thousands of healthcare providers. = SampleMD in turn shares revenue with each software partner that provides them direct access to
Slide 5: SampleMD is attractive to all stakeholders
SampleMD is attractive to all stakeholders Pharma: Provides access to prescribers and patients at the point of prescription, the most critical moment in the prescription chain Doctors: Provides information regarding drugs and the financial assistance available to patients, allowing doctors to choose
Slide 6: Key Trends—The Pharmaceutical Sales Dilemma
Key Trends—The Pharmaceutical Sales Dilemma Pharma Reps & Samples Decline In Size, Effectiveness, and ROI Sales Rep Attrition Visits With Samples (Millions) 105,000 = 120 10 90,000 100 20 75,000 80 70 60,000 so ———— 2003-2007 «2009S 2012 2007 2008 200920102011 source: Cereim State ta nts cegeimavate
Slide 7: Key Trends—Size of Target Pharmaceutical Market
Key Trends—Size of Target Pharmaceutical Market Drug Rep Visits (Detailing) a $15 billion per year market, total promotional spending of $27 billion per year ee Soe om me Se a Remon i fot Detailing, a one-to-one approach used by pharma firms to educate physicians about new products, garnered the lar
Slide 8: Key Trends—Pharma Knows It Works
Key Trends—Pharma Knows It Works Vouchers And Co-pay Coupons Are Replacing The $6B Samples Market & Improving Adherence Nearly all manufacturers offer co-payments not based on income + InJuly 2011 there were 310 co-pay card programs in the US, a 260% increase from 2009 + Co-pay cards were 1/3 of ove
Slide 9: Key Trends—The Doctor's Dilemma
Key Trends—The Doctor’s Dilemma Patients Are Resisting Increases In Co-pay Costs, Affecting Fill Rates/Adherence “First, measures for improving adherence must address financial barriers ... especially the co-payments that patients must make for medications.” Co-pay Amount Tiera Specialty Orgs Tier 3
Slide 10: Key Trends—The Doctor's Solution
Key Trends—The Doctor’s Solution Co-Pay Cards And Coupons: Letting The Facts Get In The Way Impact Of Co-Pay Offset Program On Patient ‘Adherence to BRAND Ge Increased Loyalty: 270 = Therapy hort At 200s Equivalent Co-Pay 250 40 Days 25 r aetiies 200 15 i = ote uve ea PT sear) S25ECPCoPay —_$25Co-Pa
Slide 11: Key Trends—The EHR Opportunity
Key Trends— The EHR Opportunity E-Prescribing Projected Growth A75% New Prescriptions 96 million Hl Prescription Renewal Responses 474 mittion 57 million 269 mittion 2016 PR, anos
Slide 12: SampleMD Is...
SampleMD Is... The Right Solutions, The Right Technology, The Right Opportunity SampleMD™ is now * Integrated directly into the workflow of over 250+ EMR ePrescribe systems * Reaches 200,000 health providers + The preferred way to access branded prescription vouchers, co-pay savings, and other suppo
Slide 13: Key Health Systems & ePrescribe Platforms
Key Health Systems & ePrescribe Platforms Full Integration 8 Allscripts” Cer poe CI cleveland cine — NENNICROP HEALTHCARE, Proepagiotcine Ochsner
Slide 14: SampleMD is partnering with the largest ePrescribing and EHR platforms
SampleMD is partnering with the largest ‘ePrescribing’ and electronic healthcare record (EHR) software platforms to reach more targeted care providers who are active electronic prescribers “ & eee wos Pte Manes re, HS, 82,200 ‘tes Aor 20 Allscripts has 70,000 active Physicians ePrescribe users ——— T
Slide 15: Key Health Pharmaceutical & Health Care Clients
Key Health Pharmaceutical & Health Care Clients Building the Technology Pathway to Deliver Support from Leading Pharma companies Ss 0b Novartis (Pfizer) Ce ‘5 Genentech © Wanner ees. Lty SI SUNOVION Abbott Boehringer joc, GB) cele @ Diagnostics Watson. Meastellas Phamebenn ca ¥
Slide 16: SampleMD Will Be...
SampleMD Will Be... Valuable Real Estate + eCouponing: eVouchers and eCoupons generated from the EMR/ePrescribe System—generates revenue, fuels access to EHR/EMRs + Patient Education: Offer sponsored Patient Education and Adherence Programs at the point of prescribing + Product Info & Support: Offer
Slide 17: SampleMD: Key Financial Trends
SampleMD: Key Financial Trends Quarterly eCoupon Monthly eCoupon Distributions: Distributions: Q3 2012: 90,116 November 2012: 22,049 Q4 2012: 68,771 December 2012: 19,747 Q1 2013 (-3/28): 129,266 January 2013: 20,347 February 2013: 40,224 March 2013 (-3/28): 68,695 — GPR, port
Slide 18: SampleMD: Key Financial Metrics
SampleMD: Key Financial Metrics Financial Performance: Key Stock Data (as of 2011 Gross Revenue: $1.1MM 4/3/2013): 2012 Gross Revenue: $2.049MM. Price: $1.41 Shares Out: 14.2mm primary, 2011 Net Income: ($2.11MM) additional approx. 20mm 2012 Net Income: ($364K) Weta’ 4 2012 Net income: $119k Market
Slide 19: Key Management and Contacts
Key Management and Contacts Chairman and Chief Executive Officer: Shad Stastney Founder, Vice Chairman and Chief Strategy Officer: Dave Harrell President and COO: Dave Lester Executive VP of Sales: Terry Hamilton Company contact: Shad Stastney sstastney@samplemd.com 248-651-6568 — GPR, port